ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Debt Repayment

Cash used to repay borrowings during the period.

No reported Debt Repayment figures are available to summarize.

Debt Repayment history

Currency unavailable · from the cash flow

No Debt Repayment data reported for this period type.

Debt Repayment vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Debt Repayment for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PRMEPrime Medicine, Inc.LTM Mar 2026$6M USD-200.0%—148.7%
PRQRProQR Therapeutics N.V.LTM Mar 2026€1.64M EUR+4.7%-65.2%12.2%
MGTXMeiraGTx Holdings plcLTM Mar 2026$43K USD——0.1%
STOKStoke Therapeutics, Inc.LTM Mar 2026$0 USD——0.0%
SLNSilence Therapeutics plcLTM Mar 2026$0 USD——0.0%
WVEWave Life Sciences Ltd.LTM Mar 2026$0 USD——0.0%
BNTCBenitec Biopharma Inc.LTM Mar 2026$0 USD———
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$0 USD-100.0%—0.0%
RNAAtrium Therapeutics, Inc.FY2025$0 USD——0.0%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-100.0%-65.2%0.0%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.